文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

法国重症医师对高危侵袭性念珠菌病的管理实践:多中心INSPIRE调查结果

French intensive care physicians' practices for the management of high-risk patients with invasive candidiasis: results from the multicenter INSPIRE survey.
PubMed 文献 · Ann Intensive Care · 2026-08-03
一句话结论法国ICU医师对确诊侵袭性念珠菌病管理较一致,经验性治疗决策异质性大,棘白菌素为首选一线(88.2%)。

该多中心调查通过电子邮件和学术会议向法国ICU医师发放随机临床病例模拟,共75名医师完成283例。临床怀疑时启动诊断检查的比例为72.1%;决定检测的关键因素包括腹部术后(OR=3.92)、中心静脉导管(OR=2.28)、肠外营养(OR=2)、长期抗生素暴露(OR=1.90)及医师经验>10年(OR=2.79)。棘白菌素为首选一线治疗(88.2%,n=120/136),用药依据主要为临床指南(78.3%)。确诊后降阶梯至唑类在初始棘白菌素治疗者中占87.5%,多在治疗5天后(51.2%)。结论提示经验性治疗决策需进一步统一。

要点

  • 临床怀疑侵袭性念珠菌病时,仅72.1%的模拟病例启动了诊断检查,提示诊断启动存在缺口。
  • 腹部术后(OR=3.92)、中心静脉导管(OR=2.28)、肠外营养(OR=2)和长期抗生素暴露(OR=1.90)是决定检测的独立相关因素。
  • 棘白菌素是首选一线治疗(88.2%,120/136例),用药决策主要依据临床指南(78.3%)。
  • 确诊后降阶梯至唑类:初始棘白菌素者87.5%,初始两性霉素B者60.0%,多在治疗5天后(51.2%)。
  • 经验性治疗决策异质性大,患者严重程度、免疫抑制和导管存在是指导抗真菌治疗的主要因素。

适用人群与场景

  • 法国ICU医师,通过随机临床病例模拟参与调查;结论主要反映专科大学医院中心的实践模式。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 首选一线治疗为棘白菌素(88.2%,n=120/136),用药依据依次为临床指南(78.3%)、药代/药效学特征(38.3%)、SOFA评分(29.2%)、患者状态(25.8%)和免疫抑制(20%)。
  • 确诊后降阶梯至唑类:初始棘白菌素治疗者中87.5%降阶梯,初始两性霉素B者中60.0%降阶梯,主要在治疗5天后进行(51.2%,n=64)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心调查(病例模拟),75名医师完成283例;临床怀疑时启动诊断检查的比例为72.1%。
  • 决定检测的独立相关因素:腹部术后(OR=3.92;p=0.002)、中心静脉导管(OR=2.28;p=0.04)、肠外营养(OR=2;p=0.027)、长期抗生素暴露(OR=1.90;p=0.041)、医师经验>10年(OR=2.79;p=0.014)。
  • 棘白菌素一线治疗率88.2%(120/136);降阶梯至唑类在初始棘白菌素者中87.5%,初始两性霉素B者中60.0%,51.2%在5天后降阶梯。

证据类型、等级与局限

  • 证据类型:多中心问卷调查(病例模拟);局限:结论主要反映专科大学医院中心实践模式,经验性治疗决策异质性大,需前瞻性验证。

对床旁实践的改变

  • 提示对高危侵袭性念珠菌病患者应更积极启动诊断检查(模拟中仅72.1%启动),并关注腹部术后、中心静脉导管、肠外营养和长期抗生素暴露等高危因素。
  • 经验性抗真菌治疗决策异质性大,可参考指南(78.3%医师依据)统一实践;确诊后降阶梯至唑类多在治疗5天后进行。

指南或共识出处

  • INSPIRE survey(法国多中心调查),发表于Ann Intensive Care。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Candidiasis remains a major global health challenge, with rising incidence and antifungal resistance complicating management. This multicenter survey aimed to describe diagnostic and therapeutic management practices of ICU physicians in France for high-risk invasive candidiasis cases, using randomized clinical case simulations distributed to French ICU physicians via email and academic congresses.

RESULTS: A total of 75 physicians completed 283 cases. Overall, clinical suspicion justified diagnostic investigation in 72.1% of cases. Key factors associated with the decision to test for invasive candidiasis included post-abdominal surgery (OR = 3.92; p = 0.002), central venous catheter (OR = 2.28; p = 0.04), parenteral nutrition (OR = 2; p = 0.027), prolonged antibiotic exposure (OR = 1.90; p = 0.041), and physician experience >10 years (OR = 2.79; p = 0.014). Echinocandins were the preferred first-line treatment (88.2%; n = 120/136). Their use was guided by clinical guidelines (78.3%), pharmacokinetic/pharmacodynamic profile (38.3%), SOFA score (29.2%), patient status (25.8%), and immunosuppression (20%). De-escalation to azoles upon documented mycological susceptibility occurred in 87.5% of cases initially treated with an echinocandin and 60.0% of cases initiated on amphotericin B, primarily after 5 days of treatment (51.2%; n = 64).

CONCLUSIONS: Patient severity, immunosuppression, and catheter presence were the main factors guiding antifungal treatment decisions Management of confirmed invasive candidiasis was largely consensual among respondents, whereas empirical treatment decisions were heterogeneous. While conclusions are primarily reflective of practice patterns within specialized university hospital centers, the INSPIRE survey highlights the need for enhanced training, broader access to rapid diagnostics, and improved decision-support systems to better harmonize clinical practices.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Dupont H, Mira JP, Cornet M, et al. French intensive care physicians' practices for the management of high-risk patients with invasive candidiasis: results from the multicenter INSPIRE survey. Ann Intensive Care. 2026. PMID: 42604083. doi:10.1016/j.aicoj.2026.100131

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。